Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma.

Simon Erridge Philip H PucherS R MarkarG MalietzisT AthanasiouA DarziM H SodergrenL R Jiao

Published in: The British journal of surgery (2017)

Based on these limited data, there does not appear to be a significant difference in survival between patients undergoing repeat hepatectomy or ablation for recurrent HCC. The results also identify important negative prognostic factors (short disease-free interval, multiple hepatic metastases and large hepatic metastases), which may influence choice of treatment.

Keyphrases

prognostic factors
systematic review
patients undergoing
electronic health record
combination therapy
atrial fibrillation
decision making
meta analyses
liver metastases